WHEN IT arrived finally in Kinshasa on Thursday September 5, one could only wonder at the time and effort it took for a small consignment of vaccines from Europe to reach the Democratic Republic of Congo (DRC), the epicentre of the mpox (earlier called monkeypox) outbreak in Africa. The picture of the container of desperately needed vaccines, 100,000 doses donated by the EU, unloaded on a trolley at the airport, is reflective of the global politics, economics and bureaucratic heaviness that dictate how an epidemic in a poor country is handled.
Two days later, as this column was being written, another 200,000 doses sent by the EU arrived in the DRC capital and a few other African countries where mpox cases are spiking. Yet, together the donation is just a fraction of what is needed to combat the epidemic which has so far hit a dozen countries in the continent.
In the eight months of 2024, over 18,000 cases of mpox have been reported in DRC alone which has recorded 629 deaths, the majority of them children. As before, and most recently with the COVID-19 pandemic, Africa is desperately short of vaccines, not to mention testing kits and therapies to help fight a disease which is a throwback to the times when smallpox was the deadliest scourge in the world. DRC needs 3.5 million doses to stop the spread of the disease while other African states need 10 million doses. Vaccine though is the best tool to control the epidemic and what works is the smallpox vaccine; who has any shots to spare?
This story is from the {{IssueName}} edition of {{MagazineName}}.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.
Already a subscriber ? Sign In
This story is from the {{IssueName}} edition of {{MagazineName}}.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.
Already a subscriber? Sign In
Trade On Emissions
EU's Carbon Border Adjustment Mechanism, a tariff on imports, is designed to protect European industries in the guise of climate action.
'The project will facilitate physical and cultural decimation of indigenous people'
The Great Nicobar Project has all the hallmarks of a disaster-seismic, ecological, human. Why did it get the go-ahead?
TASTE IT RED
Popularity of Karnataka's red jackfruit shows how biodiversity can be conserved by ensuring that communities benefit from it
MANY MYTHS OF CHIPKO
Misconceptions about the Chipko movement have overshadowed its true objectives.
The politics and economics of mpox
Africa's mpox epidemic stems from delayed responses, neglect of its health risks and the stark vaccine apartheid
Emerging risks
Even as the world gets set to eliminate substances threatening the ozone layer, climate change and space advancement pose new challenges.
JOINING THE CARBON CLUB
India's carbon market will soon be a reality, but will it fulfil its aim of reducing emissions? A report by PARTH KUMAR and MANAS AGRAWAL
Turn a new leaf
Scientists join hands to predict climate future of India's tropical forests
Festering troubles
The Democratic Republic of Congo struggles to contain mpox amid vaccine delays, conflict and fragile healthcare.
India sees unusual monsoon patterns
THE 2024 southwest monsoon has, between June 1 and September 1, led to excess rainfall in western and southern states such as Gujarat, Maharashtra and Tamil Nadu, while others like Nagaland, Manipur and Punjab recorded a deficit.